Authors:
Geisler, J
Detre, S
Berntsen, H
Ottestad, L
Lindtjorn, B
Dowsett, M
Lonning, PE
Citation: J. Geisler et al., Influence of neoadjuvant anastrozole (Arimidex) on intratumoral estrogen levels and proliferation markers in patients with locally advanced breast cancer, CLIN CANC R, 7(5), 2001, pp. 1230-1236
Citation: Pe. Lonning, Aromatase inhibitors and inactivators in breast cancer - These potent inhibitors of oestrogen synthesis may be superior to tamoxifen, BR MED J, 323(7318), 2001, pp. 880-881
Authors:
Lonning, PE
Taylor, PD
Anker, G
Iddon, J
Wie, L
Jorgensen, LM
Mella, O
Howell, A
Citation: Pe. Lonning et al., High-dose estrogen treatment in postmenopausal breast cancer patients heavily exposed to endocrine therapy, BREAST CANC, 67(2), 2001, pp. 111-116
Authors:
Sorlie, T
Perou, CM
Tibshirani, R
Aas, T
Geisler, S
Johnsen, H
Hastie, T
Eisen, MB
van de Rijn, M
Jeffrey, SS
Thorsen, T
Quist, H
Matese, JC
Brown, PO
Botstein, D
Lonning, PE
Borresen-Dale, AL
Citation: T. Sorlie et al., Gene expression patterns of breast carcinomas distinguish tumor subclasseswith clinical implications, P NAS US, 98(19), 2001, pp. 10869-10874
Authors:
Jain, AN
Chin, K
Borresen-Dale, AL
Erikstein, BK
Lonning, PE
Kaaresen, R
Gray, JW
Citation: An. Jain et al., Quantitative analysis of chromosomal CGH in human breast tumors associatescopy number abnormalities with p53 status and patient survival, P NAS US, 98(14), 2001, pp. 7952-7957
Authors:
Helle, SI
Ueland, T
Ekse, D
Froland, SS
Holly, JMP
Lonning, PE
Aukrust, P
Citation: Si. Helle et al., The insulin-like growth factor system in human immunodeficiency virus infection: Relations to immunological parameters, disease progression, and antiretroviral therapy, J CLIN END, 86(1), 2001, pp. 227-233
Authors:
Geisler, S
Lonning, PE
Aas, T
Johnsen, H
Fluge, O
Haugen, DF
Lillehaug, JR
Akslen, LA
Borresen-Dale, AL
Citation: S. Geisler et al., Influence of TP53 gene alterations and c-erbB-2 expression on the responseto treatment with doxorubicin in locally advanced breast cancer, CANCER RES, 61(6), 2001, pp. 2505-2512
Authors:
Helle, SI
Geisler, J
Anker, GB
Leirvaag, B
Holly, JMP
Lonning, PE
Citation: Si. Helle et al., Alterations in the insulin-like growth factor system during treatment withdiethylstilboestrol in patients with metastatic breast cancer, BR J CANC, 85(2), 2001, pp. 147-151
Authors:
Helle, SI
Geisler, S
Aas, T
Paulsen, T
Holly, JMP
Lonning, PE
Citation: Si. Helle et al., Plasma insulin-like growth factor binding protein-3 proteolysis is increased in primary breast cancer, BR J CANC, 85(1), 2001, pp. 74-77
Citation: J. Geisler et al., A novel HPLC-RIA method for the simultaneous detection of estrone, estradiol and estrone sulphate levels in breast cancer tissue, J STEROID B, 72(5), 2000, pp. 259-264
Authors:
Lonning, PE
Bajetta, E
Murray, R
Tubiana-Hulin, M
Eisenberg, PD
Mickiewicz, E
Celio, L
Pitt, P
Mita, M
Aaronson, NK
Fowst, C
Arkhipov, A
di Salle, E
Polli, A
Massimini, G
Citation: Pe. Lonning et al., Activity of exemestane in metastatic breast cancer after failure of nonsteroidal aromatase inhibitors: A phase II trial, J CL ONCOL, 18(11), 2000, pp. 2234-2244
Authors:
Perou, CM
Sorlie, T
Eisen, MB
van de Rijn, M
Jeffrey, SS
Rees, CA
Pollack, JR
Ross, DT
Johnsen, H
Aksien, LA
Fluge, O
Pergamenschikov, A
Williams, C
Zhu, SX
Lonning, PE
Borresen-Dale, AL
Brown, PO
Botstein, D
Citation: Cm. Perou et al., Molecular portraits of human breast tumours, NATURE, 406(6797), 2000, pp. 747-752
Authors:
Helle, SI
Lundgren, S
Geisler, S
Ekse, D
Holly, JMP
Lonning, PE
Citation: Si. Helle et al., Effects of treatment with megestrol acetate on the insulin-like growth factor system: Time and dose dependency, EUR J CANC, 35(7), 1999, pp. 1070-1075
Authors:
Love, RR
Anker, G
Yang, YH
Refsum, H
Ueland, PM
Lonning, PE
Lien, EA
Citation: Rr. Love et al., Serum homocysteine levels in postmenopausal breast cancer patients treatedwith tamoxifen, CANCER LETT, 145(1-2), 1999, pp. 73-77
Authors:
Geisler, J
Omsjo, IH
Helle, SI
Ekse, D
Silsand, T
Lonning, PE
Citation: J. Geisler et al., Plasma oestrogen fractions in postmenopausal women receiving hormone replacement therapy: influence of route of administration and cigarette smoking, J ENDOCR, 162(2), 1999, pp. 265-270